
REPL: Is Replimune Group, Inc. Halal?
Replimune Group, Inc.
$5.35
-38.01%
Market Cap: 449.1M
Compliance Status
Halal
Screened on Sep 2, 2026 · AAOIFI Standard 21
Good
Is Replimune Group, Inc. (REPL) halal? Halal. Based on AAOIFI screening, Replimune Group, Inc. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 76/100 (Grade: B+).
Quote this verdict
HalalScreener rates Replimune Group, Inc. (REPL) Halal, 76/100, grade B+ under AAOIFI Standard 21, screened Sep 2, 2026. Source: https://halalscreener.app/en/stock/REPL
Business activity
What the company sells is permissible.
Company debt
Well clear of the limitHow much the company borrows, compared to its total value. AAOIFI allows up to 30%.
What this means for you
You can own REPL
It passes both the business activity and financial ratio screens under AAOIFI Standard 21.
Purification amount is Pro
We have screened REPL's prohibited income, but the exact share you would need to purify is part of Pro.
About Replimune Group, Inc.
Replimune Group, Inc. is a biotechnology enterprise dedicated to pioneering oncolytic immuno-gene therapies aimed at treating various cancers. The company leverages its proprietary Immunotherapy platform to engineer and advance novel therapeutic candidates designed to activate the body's immune system against malignant cells. Its leading experimental drug, RP1, is a selectively replicating variant of the herpes simplex virus 1. This candidate is presently in Phase I/II clinical trials for a range of solid tumors and has also progressed to Phase II trials specifically for patients with cutaneous squamous cell carcinoma. Replimune is additionally developing RP2, an anti-CTLA-4 antibody-like protein, which is undergoing Phase I clinical assessment. Its purpose is to counteract the immune system's suppression often mediated by CTLA-4. Furthermore, RP3, also in Phase I clinical trials, is engineered to express immune-activating proteins that stimulate T cells. Established in 2015, Replimune Group, Inc. maintains its corporate headquarters in Woburn, Massachusetts.
Sector: Healthcare · Industry: Biotechnology
Shariah Compliance Status
Compliance History
Halalnow
since Aug 2026
Under Review
until the change above
Not Halal
until the change above
Tracked since May 2026. Updates automatically on each re-screen.
More Healthcare Stocks
Track REPL and 6,200+ stocks with AI insights
Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.
Frequently Asked Questions
Is Replimune Group, Inc. (REPL) halal to invest in?
Why did Replimune Group, Inc. get a B+ compliance rating?
What could change Replimune Group, Inc.'s Shariah verdict?
How often is Replimune Group, Inc. re-screened for Shariah compliance?
Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.